Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hannah Storrie-White"'
Autor:
Jay C. Strum, Rajesh K. Malik, Patrick J. Roberts, Ewoud Jan Van Hoogdalem, Henko Tadema, Hannah Storrie-White, Renger G. Tiessen, William A. Wargin, John E. Bisi, Shenghui He, Karenann M. Makhuli, Jessica A. Sorrentino, Norman E. Sharpless
Publikováno v:
Science Translational Medicine. 9
Conventional cytotoxic chemotherapy is highly effective in certain cancers, but causes dose-limiting damage to normal proliferating cells, especially hematopoietic stem and progenitor cells (HSPCs). Serial exposure to cytotoxics causes a long-term he
Autor:
Hannah Storrie White, Elizabeth Nieman, M. Fiordalisi, Andrew E. Balber, Alan Nguyen, N. Meadows, D. Hickerson, Tracy Gentry, Sandra J. Foster, James M. Hinson
Publikováno v:
Cytotherapy. 16:1545-1557
Background aims Delivery of cell-based therapies through the carotid artery with the use of an intra-arterial catheter could introduce aggregates and cause focal ischemia in the brain. We developed a pulse-width flow cytometry method for aggregate de
Autor:
Yevgeny Brudno, Herman H. Vandenburgh, Corey M. McCann, David J. Mooney, Cathal J. Kearney, John Koullias, Nhi Ho, Christine A. Cezar, Erin M. Anderson, Juan Carlos Tapia, Jeff W. Lichtman, Kangwon Lee, Hannah Storrie-White, Dmitry Shvartsman
Tissue reinnervation following trauma, disease, or transplantation often presents a significant challenge. Here, we show that the delivery of vascular endothelial growth factor (VEGF) from alginate hydrogels ameliorates loss of skeletal muscle innerv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a16deb58f604923c915f8ac33b38e27
https://europepmc.org/articles/PMC4089004/
https://europepmc.org/articles/PMC4089004/
Autor:
James P. Stice, Jay C. Strum, Alex Y. Yllanes, Hannah Storrie White, Holly M. Alley, Donald P. McDonnell, Suzanne E. Wardell, Scott A. Lawrence
Publikováno v:
Cancer Research. 76:2820-2820
Introduction: Resistance to endocrine therapies, via expression of mutations or variants of the androgen receptor (AR), remains an impediment to enduring therapeutic responses in advanced castration resistant prostate cancer (CRPC). AR-dependent upre
Publikováno v:
Journal of Stem Cell Research & Therapy.
Human stem cell populations that express high aldehyde dehydrogenase activity [ALDHbr cells] have angiogenic activity in preclinical models and have been used safely to treat patients in early clinical trials. Bone marrow ALDHbr cells are being devel